Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association

MA Konstam, MS Kiernan, D Bernstein, B Bozkurt… - Circulation, 2018 - Am Heart Assoc
Background and Purpose: The diverse causes of right-sided heart failure (RHF) include,
among others, primary cardiomyopathies with right ventricular (RV) involvement, RV …

Escalating and de-escalating temporary mechanical circulatory support in cardiogenic shock: a scientific statement from the American Heart Association

BJ Geller, SS Sinha, NK Kapur, M Bakitas, LB Balsam… - Circulation, 2022 - Am Heart Assoc
The use of temporary mechanical circulatory support in cardiogenic shock has increased
dramatically despite a lack of randomized controlled trials or evidence guiding clinical …

2019 EACTS Expert Consensus on long-term mechanical circulatory support

EV Potapov, C Antonides… - European Journal of …, 2019 - academic.oup.com
Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …

The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary

D Feldman, SV Pamboukian, JJ Teuteberg… - The Journal of Heart and …, 2013 - Elsevier
CO-CHAIRS: Feldman D: Minneapolis Heart Institute, Minneapolis, Minnesota, Georgia
Institute of Technology and Morehouse School of Medicine; Pamboukian SV: University of …

Mechanical circulatory support devices for acute right ventricular failure

NK Kapur, ML Esposito, Y Bader, KJ Morine… - Circulation, 2017 - Am Heart Assoc
Right ventricular (RV) failure remains a major cause of global morbidity and mortality for
patients with advanced heart failure, pulmonary hypertension, or acute myocardial infarction …

Predicting the risk of right ventricular failure in patients undergoing left ventricular assist device implantation: a systematic review

C Frankfurter, M Molinero… - Circulation: Heart …, 2020 - Am Heart Assoc
Background: Right ventricular failure (RVF) is a cause of major morbidity and mortality after
left ventricular assist device (LVAD) implantation. It is, therefore, integral to identify patients …

Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes

F Gustafsson, JG Rogers - European journal of heart failure, 2017 - Wiley Online Library
Despite improvements in pharmacological therapy and pacing, prognosis in advanced heart
failure (HF) remains poor, with a 1‐year mortality of 25–50%. While heart transplantation …

Left ventricular assist devices: synergistic model between technology and medicine

JJ Han, MA Acker, P Atluri - Circulation, 2018 - Am Heart Assoc
Ventricular assist device has rapidly emerged as a durable and safe therapy for end-stage
heart failure patients with> 22 000 implantations to date. Though originally conceived for …

Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee

JC Fang, GA Ewald, LA Allen, J Butler… - Journal of cardiac …, 2015 - Elsevier
We propose that stage D advanced heart failure be defined as the presence of progressive
and/or persistent severe signs and symptoms of heart failure despite optimized medical …

Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta‐analysis of observational studies

D Bellavia, A Iacovoni, C Scardulla… - European journal of …, 2017 - Wiley Online Library
Right ventricular failure (RVF) after left ventricular assist device (LVAD) implantation is
associated with increased morbidity and mortality, but the identification of LVAD candidates …